Clinical trial
Molecular Assessment of Artemisinin Resistance Markers, K13 Kelch Propeller and Multi-drug Resistant Gene Polymorphism in Eastern and Western Border Areas of Myanmar
NCT02198573 is registered in ClinicalTrials.gov with Myat Htut Nyunt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Assessment of Artemisinin Resistance Markers, K13 Kelch Propeller and Multi-drug Resistant Gene Polymorphism in Eastern and Western Border Areas of Myanmar
- Lead sponsor
- Myat Htut Nyunt
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- June 30, 2014
- Enrollment
- 91 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
day-3 positive of parasitaemia, prevalence of drug resistance gene mutation